Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Conrey

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Haematologica|January 28, 2017
Prostacyclin-analog therapy in sickle cell pulmonary hypertensionNargues A Weir, Rehan Saiyed, Shoaib Alam, et al.
Scandinavian Journal of Pain|October 4, 2017
Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemiaDeepika S Darbari, Kathleen J Vaughan, Katherine Roskom, et al.
Blood Advances|September 12, 2024
Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylationKang Le, Xunde Wang, Jonathan Chu, et al.
The Lancet. Haematology|May 5, 2015
Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trialCaterina P Minniti, Alexander M Gorbach, Dihua Xu, et al.
Blood. Red Cells & Iron|March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell diseaseAnna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Haematologica|January 28, 2017
Prostacyclin-analog therapy in sickle cell pulmonary hypertensionNargues A Weir, Rehan Saiyed, Shoaib Alam, et al.
Scandinavian Journal of Pain|October 4, 2017
Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemiaDeepika S Darbari, Kathleen J Vaughan, Katherine Roskom, et al.
Blood Advances|September 12, 2024
Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylationKang Le, Xunde Wang, Jonathan Chu, et al.
The Lancet. Haematology|May 5, 2015
Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trialCaterina P Minniti, Alexander M Gorbach, Dihua Xu, et al.
Blood. Red Cells & Iron|March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell diseaseAnna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.
Pageof 2